A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
James S Talks
Advertisement
Articles by James S Talks
Advertisement
Latest Updated Articles
Assessing the quality of real-world evidence in retinal diseasesNovember 11th 2021
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Port Delivery System Therapies in Retinal Vascular Diseases
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
5